These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2239456)
21. [Depression and Parkinson's disease: neurobiologic foundations and therapeutic management]. Giménez-Roldán S; Dobato JL; Mateo D; González Alvarez M; Novillo Infantes MJ; Giménez-Zuccarelli M Neurologia; 1996 Nov; 11(9):332-40. PubMed ID: 9004744 [TBL] [Abstract][Full Text] [Related]
22. Serotonin: la chica de moda in biological psychiatry? Banki CM Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139 [No Abstract] [Full Text] [Related]
23. [Depressive symptoms and motor condition in Parkinson's disease patients]. Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264 [TBL] [Abstract][Full Text] [Related]
25. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link. Stahl SM J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732 [TBL] [Abstract][Full Text] [Related]
26. Minor depression and brain perfusion images in Parkinson's disease. Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687 [TBL] [Abstract][Full Text] [Related]
27. Depression in multiple system atrophy and in idiopathic Parkinson's disease: a pilot comparative study. Pilo L; Ring H; Quinn N; Trimble M Biol Psychiatry; 1996 May; 39(9):803-7. PubMed ID: 8731521 [TBL] [Abstract][Full Text] [Related]
30. The serotonin system and aggressive personality disorder. Siever L; Trestman RL Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():33-9. PubMed ID: 8201245 [No Abstract] [Full Text] [Related]
31. New approaches to the treatment of depression. Leonard BE J Clin Psychiatry; 1996; 57 Suppl 4():26-33. PubMed ID: 8636063 [TBL] [Abstract][Full Text] [Related]
32. [Locomotion and depression. Clinical and physiological aspects of gait alterations in Parkinson's disease and major depression]. Wendorff T; Linnemann M; Lemke MR Fortschr Neurol Psychiatr; 2002 Jun; 70(6):289-96. PubMed ID: 12048618 [TBL] [Abstract][Full Text] [Related]
37. Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy. Maloteaux JM; Laterre EC; Laduron PM; Javoy-Agid F; Agid Y Mov Disord; 1988; 3(3):255-62. PubMed ID: 3193963 [TBL] [Abstract][Full Text] [Related]
38. [Changes in functional interrelations of neuromediator systems during aging and the development of neuropsychological pathology of old age (review)]. Burchinskiĭ SG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1394-1400. PubMed ID: 2866651 [No Abstract] [Full Text] [Related]
39. In vivo assessment of aging changes in serotonin function. Meltzer CC; Reynolds CF Neuropsychopharmacology; 1999 Aug; 21(2):323-4. PubMed ID: 10432481 [No Abstract] [Full Text] [Related]